Keratoconus
Rokowania, prognozy i postęp choroby
Keratoconus to postępująca, niezapalna choroba rogówki, charakteryzująca się ścieńczeniem i stożkowatym zniekształceniem, prowadzącym do upośledzenia widzenia. Choroba zwykle rozpoczyna się w okresie dojrzewania i postępuje przez 10-20 lat, stabilizując się w trzeciej lub czwartej dekadzie życia, choć możliwa jest późna progresja. Czynniki predykcyjne progresji obejmują wyższe wartości keratometrii maksymalnej (Kmax), obecność alergii, młodszy wiek diagnozy oraz pocieranie oczu. Nowoczesne metody oparte na głębokim uczeniu umożliwiają przewidywanie progresji z około 80% dokładnością, co jest kluczowe dla wczesnej interwencji i zapobiegania utracie wzroku. Sieciowanie rogówki (CXL), zwłaszcza protokół nieprzyśpieszony z usunięciem nabłonka (epi-off) oraz przyśpieszone przeznabłonkowe (ATE-CXL), skutecznie zatrzymują progresję, szczególnie u pacjentów z wyższymi wartościami Kmax i cieńszą centralną grubością rogówki (CCT). Pacjenci odnoszą korzyści z CXL niezależnie od stadium choroby, choć lepsze wyniki w ostrości wzroku obserwuje się we wczesnych stadiach keratoconusa.
Prognozy dla Keratoconusa
Keratoconus (stożek rogówki) to postępująca, niezapalna choroba rogówki, charakteryzująca się ścieńczeniem i stożkowatym zniekształceniem rogówki, prowadzącym do upośledzenia widzenia. Prognozy dla pacjentów z keratoconusem zależą od wielu czynników, w tym od stopnia zaawansowania choroby, zastosowanego leczenia oraz indywidualnych cech pacjenta.123
Naturalny przebieg choroby
Naturalny przebieg keratoconusa może być bardzo zróżnicowany. U niektórych pacjentów występują łagodne przypadki, które nie postępują, podczas gdy u innych choroba może rozwijać się znacznie szybciej. Nikt nie jest w stanie precyzyjnie przewidzieć przebiegu w każdym indywidualnym przypadku.1 Typowo keratoconus rozpoczyna się w okresie dojrzewania i jest diagnozowany w późnych latach nastoletnich lub wczesnych dwudziestych. Diagnoza choroby w młodym wieku może wskazywać na większe ryzyko ciężkiego przebiegu w późniejszym życiu.1
Najczęściej keratoconus postępuje przez okres 10-20 lat, po czym zwykle stabilizuje się w trzeciej i czwartej dekadzie życia. Dane sugerują, że choroba, choć postępująca, stabilizuje się po pewnym czasie u większości pacjentów.12 Warto jednak pamiętać, że późno pojawiająca się progresja keratoconusa jest istotnym zjawiskiem, które należy uwzględniać podczas planowania leczenia, mimo tradycyjnego przekonania, że choroba nie postępuje po 30. roku życia z powodu naturalnie powstających wiązań krzyżowych w rogówce.3
Niektóre oczy z keratoconusem mogą jednak nadal wykazywać progresję, czego mechanizm nie został jeszcze w pełni wyjaśniony, ale może być związany z pocieraniem oczu.1
Czynniki predykcyjne progresji
Zidentyfikowano kilka czynników, które mogą przewidywać progresję keratoconusa:
- Stromość rogówki – wyższe wartości keratometrii maksymalnej (Kmax) są związane z szybszą progresją choroby. Badania wykazały, że bardziej strome rogówki progresują szybciej i wymagają ścisłej obserwacji.1
- Alergia – obecność alergii jest predyktorem progresji keratoconusa.2
- Wiek – diagnoza w młodszym wieku często wiąże się z większym ryzykiem progresji.1
- Pocieranie oczu – jest to modyfikowalny czynnik ryzyka, który może wpływać na progresję choroby.2
Badania z wykorzystaniem głębokiego uczenia (deep learning) wykazują, że możliwe jest przewidywanie progresji keratoconusa i potrzeby wykonania sieciowania rogówki (CXL) z około 80% prawdopodobieństwem, przy użyciu map osiowych lub pachymetrycznych rogówki w połączeniu z wiekiem pacjenta.2 Taka wczesna i dokładna detekcja progresji keratoconusa ma kluczowe znaczenie dla zapobiegania utracie wzroku i skutecznego leczenia choroby.3
Prognozy w zależności od zastosowanego leczenia
Wraz z odpowiednim leczeniem, rokowanie dla pacjentów z keratoconusem jest dobre.11 Dostępne obecnie metody terapeutyczne pozwalają większości pacjentów prowadzić normalne życie.1
Sieciowanie rogówki (CXL)
Sieciowanie rogówki (Corneal Cross-Linking, CXL) jest wysoce skuteczną metodą leczenia keratoconusa. Głównym celem CXL jest zatrzymanie progresji choroby.123 Badania wskazują, że CXL jest bardziej skuteczne u pacjentów z bardziej zaawansowaną chorobą, co przejawia się wyższymi wartościami Kmaxpre, wyższym ekwiwalentem sferycznym (SEpre) i wyższą ostrością wzroku LogMARpre.31
Różne protokoły CXL mogą dawać różne wyniki:
- Protokół nieprzyśpieszony z usunięciem nabłonka (epi-off) wiąże się z większym spłaszczeniem krzywizny rogówki, ale nie wykazuje lepszego wpływu na ostrość wzroku w porównaniu z innymi protokołami CXL.42
- Przyśpieszone przeznabłonkowe sieciowanie rogówki (ATE-CXL) jest bezpieczną i skuteczną metodą leczenia keratoconusa. Pacjenci z cieńszą centralną grubością rogówki (CCT) i wyższymi wartościami Kmax mają większe szanse na poprawę po ATE-CXL.1
Badania sugerują również, że pacjenci odnoszą korzyści z CXL niezależnie od zmodyfikowanego stadium Krumeicha. Jednakże zaobserwowano tendencje w kierunku stosunkowo większej poprawy ostrości wzroku w grupie z wczesnym stadium keratoconusa.1
Leczenie zaćmy u pacjentów z keratoconusem
Pacjenci z keratoconusem mogą rozwijać zaćmę wcześniej niż osoby bez tej choroby.1 Fakoemulsyfikacja z implantacją soczewki wewnątrzgałkowej (IOL) okazała się bezpieczna i skuteczna, a dokładność była również dobra w łagodnym keratoconusie, ale nie w ciężkim keratoconusie.11
Należy pamiętać, że:
- U pacjentów z zaawansowanym keratoconusem wystąpiło duże przesunięcie w kierunku nadwzroczności, gdy do obliczenia mocy IOL używano odczytów keratometrycznych.22
- Keratoconus prowadzi do nadwzrocznego błędu predykcji, który nasila się wraz ze stadium keratoconusa (od +0,44 D w stadium 1 do +3,01 D w stadium 3 dla formuły SRK/T).1
- Dokładność kalkulacji mocy IOL pogarsza się wraz ze wzrostem stadium keratoconusa.2
Aktualnie zaleca się stosowanie formuły Kane dla keratoconusa u pacjentów z keratoconusem, przy czym formuły Barrett lub SRK/T są kolejnymi najdokładniejszymi formułami. Podczas informowania pacjentów o możliwych wynikach (przy użyciu formuły Kane dla keratoconusa), należy podać następujące dane: 60% przypadków w granicach 0,50 D, jeśli średnia keratometria wynosi ≤48 dioptrii; 40%, jeśli średnia keratometria wynosi 48-53; i 25%, jeśli średnia keratometria wynosi ≥53 D.1
Konieczność przeszczepu rogówki
Około 10-20% pacjentów z keratoconusem ostatecznie wymaga przeszczepu rogówki, ale liczba ta prawdopodobnie wzrasta, gdy nie jest dostępna dobra opieka w zakresie sztywnych soczewek kontaktowych i spada przy wczesnym leczeniu CXL.1 Progresja keratoconusa do stadium, w którym przeszczep rogówki (keratoplastyka drążąca, PK) jest wymagany do rehabilitacji wzrokowej, ma znaczące implikacje dla dotkniętych pacjentów.1
Konsekwencje braku leczenia
Nieleczony keratoconus może prowadzić do trwałej utraty wzroku. Zmiany w rogówce utrudniają ogniskowanie oka z okularami lub bez, lub ze standardowymi miękkimi soczewkami kontaktowymi.1 W zaawansowanych przypadkach, wybrzuszenie rogówki może prowadzić do miejscowego pęknięcia błony Descemeta, wewnętrznej warstwy rogówki. Chociaż jest to niepokojące dla pacjenta, efekt jest zwykle tymczasowy i po okresie sześciu do ośmiu tygodni rogówka zwykle wraca do swojej wcześniejszej przejrzystości. Regenerację można wspomagać niechirurgicznie poprzez opatrunek z osmotycznym roztworem soli fizjologicznej.2
Nowe technologie w prognozowaniu
Rozwój technologii opartych na sztucznej inteligencji, w tym modeli opartych na transformerach, oferuje znaczący postęp w dziedzinie zarządzania keratoconusem. Te nowe podejścia pozwalają na wcześniejsze i dokładniejsze interwencje, co ostatecznie poprawia wyniki leczenia pacjentów.4
Model oparty na transformerach przewyższa tradycyjne metody uczenia maszynowego, takie jak SVM, lasy losowe i CNN, pod względem dokładności, precyzji, czułości i F-score, przy jednoczesnym utrzymaniu krótszych czasów wykonania, co czyni go wysoce wydajnym i skutecznym narzędziem dla środowisk klinicznych.1
Podsumowanie rokowań
Rokowanie dla pacjentów z keratoconusem jest dobre, jeśli stan jest leczony w odpowiednim czasie.1 Chociaż trudno jest przewidzieć, jak szybko lub jak bardzo choroba rozwinie się u poszczególnych osób, nie prowadzi ona do całkowitej ślepoty. W najgorszych przypadkach wzrok może być bardzo słaby, ale dzięki dzisiejszym terapiom większość ludzi może prowadzić normalne życie.1
Najczęściej wzrok i codzienne życie są zakłócane tylko wtedy, gdy pacjenci zmieniają lub przyzwyczajają się do soczewek, lub czekają na stabilizację wzroku po przeszczepie rogówki.2 Dzięki wczesnej diagnozie i odpowiedniemu leczeniu, większość pacjentów z keratoconusem może skutecznie zarządzać swoim stanem i zachować funkcjonalny wzrok przez całe życie.22
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Keratoconus: Symptoms, Causes & Treatmenthttps://my.clevelandclinic.org/health/diseases/14415-keratoconus
With treatment, the outlook for someone with keratoconus is good. […] Every person is different. Some people have mild cases of keratoconus that dont progress. Other people have cases that do progress. No one can predict what will happen in every case. […] Untreated keratoconus can lead to permanent vision loss. The changes to the cornea make it difficult for your eye to focus with or without eyeglasses or standard soft contact lenses.
- #1 Keratoconus – Wikipediahttps://en.wikipedia.org/wiki/Keratoconus
Patients with keratoconus typically present initially with mild astigmatism and myopia, commonly at the onset of puberty, and are diagnosed by the late teenage years or early 20s. […] A diagnosis of the disease at an early age may indicate a greater risk of severity in later life. […] The course of the disorder can be quite variable, with some patients remaining stable for years or indefinitely, while others progress rapidly or experience occasional exacerbations over a long and otherwise steady course. Most commonly, keratoconus progresses for a period of 10 to 20 years before the course of the disease generally ceases in the third and fourth decades of life. […] In advanced cases, bulging of the cornea can result in a localized rupture of Descemet’s membrane, an inner layer of the cornea. […] Although disconcerting to the patient, the effect is normally temporary and after a period of six to eight weeks, the cornea usually returns to its former transparency. […] The recovery can be aided nonsurgically by bandaging with an osmotic saline solution.
- #1https://journals.lww.com/ijo/fulltext/2024/72040/current_concepts_in_the_management_of_cataract.11.aspx
However, certain eyes with KCN do progress, the natural mechanism of which is not yet determined but could be linked to the pursued eye rubbing. […] Successful cataract surgery depends on the careful management of inflammation and modifiable risk factors such as eye rubbing, which can impact prognosis and outcomes. […] The management of cataracts in patients with KCN requires extensive preoperative intraoperative and postoperative planning to achieve optimal visual outcomes.
- #1 Natural history and predictors for progression in pediatric keratoconus | Scientific Reportshttps://www.nature.com/articles/s41598-023-32176-5
We studied the demographic and clinical predictors associated with keratoconus progression in a pediatric population. […] The general Kaplan-Meyer curves showed no differences between RE/LE or BE/WE. […] Steepest corneas are predictors of faster progression. Allergy is also a predictor of keratoconus progression in RE. […] The present work reveals that the major factors associated with progression were: Kmax55 D (for LE, BE, and WE), and presence of allergy (for RE). […] Our data reinforce that the steepest corneas are associated with faster progression and therefore need close follow-up. The presence of allergy is also a predictor of keratoconus progression.
- #1 Predicting Keratoconus Progression and Need for Corneal Crosslinking Using Deep Learninghttps://www.mdpi.com/2077-0383/10/4/844
We aimed to predict keratoconus progression and the need for corneal crosslinking (CXL) using deep learning (DL). […] The primary purpose of CXL is to halt the progression of keratoconus. […] However, there are no definitive criteria for predicting keratoconus progression at present. […] Therefore, a method for predicting the progression and the need for CXL in keratoconus cases at the first examination is required. […] In the present work, we aimed to determine the need for CXL to halt keratoconus progression using DL. […] The predictive performance of keratoconus progression is shown in Table 2 and Figure 4. […] When the possibility for keratoconus progression was combined with patientsâ age, the AUC values were 0.783 (0.721â0.845) with the axial map, 0.784 (0.722â0.846) with the corneal pachymetry map, and 0.814 (0.755â0.872) using both maps. […] We attempted to predict the exacerbation of keratoconus that required CXL aftertime using DL and showed that the axial map or the pachymetry map combined with the patientsâ age were useful indicators of the need for CXL, with about 80% probability.
- #1 Keratoconus and Possible Treatments | CollaborativeEYEhttps://collaborativeeye.com/articles/2018-jan-feb/keratoconus-and-possible-treatments/
The prognosis is good if the condition is treated in a timely manner. […] The prognosis for keratoconus, if treated, is excellent.
- #1 Keratoconus – Sjónlaghttps://en.sjonlag.is/EyeCare/Keratoconus/
Although it is difficult to predict how fast or how much the disease will develop per individual, the disease does not lead to total blindness. […] In the worst cases, the sight may be very bad. With today’s therapies, most people to maintain a normal life. […] Most of the time, vision and daily life is only disrupted while people are changing or getting used to lenses, or waiting for the vision to stabilize after corneal transplantation.
- #1 Predicting factors for the efficacy of cross-linking for keratoconus – PubMedhttps://pubmed.ncbi.nlm.nih.gov/35113959/
Purpose: To evaluate predictors for success in corneal crosslinking (CXL) for keratoconus in a large cohort and extended follow-up. […] Conclusion: CXL for keratoconus is a highly effective treatment, as evident by its effects on the outcome measures: Delta Kmax and Delta LogMAR. CXL was more successful in eyes with high Kmaxpre, high SEpre, and high LogMARpre, which express disease severity. The non-accelerated epithelium-off protocol was associated with greater flattening of corneal curvature but did not show a better effect on visual acuity as compared to the other CXL protocols.
- #1 Predicting factors for the efficacy of cross-linking for keratoconus | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263528
We also demonstrated that an improvement of visual function post-CXL was significantly affected by a higher LogMARpre, a higher SEpre, and a lower MeanKpre. […] Overall, these results show that in patients with more advanced disease, CXL might have a more potent effect. […] In univariate and multivariate analysis, non-accelerated CXL was correlated with significantly more negative Delta Kmax compared to accelerated CXL. […] In univariate and multivariate analysis, higher Kmaxpre was correlated with significantly more negative Delta Kmax. […] Higher baseline spherical equivalent (SE) correlated with greater improvement of Kmax in univariate analysis and visual acuity in multivariate analysis.
- #1 Predictive factors of the accelerated transepithelial corneal cross-linking outcomes in keratoconus | BMC Ophthalmology | Full Texthttps://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-021-02235-4
This study aimed to evaluate the clinical outcomes and assess preoperative characteristics that may predict outcomes in keratoconus 1 year after accelerated transepithelial corneal cross-linking (ATE-CXL). […] ATE-CXL is a safe and effective treatment for keratoconus patients. Patients with thinner CCT and higher Kmax values are more likely to benefit from ATE-CXL. […] It was found that the preoperative values of CCT and Kmax were predictors determining progression postoperatively. […] Our study suggests that ATE-CXL is a safe and effective treatment for patients with keratoconus. Patients with thinner CCT and higher Kmax values were most likely to improve after ATE-CXL, but the long-term effects are yet to be elucidated and need further observation.
- #1 Impact of keratoconus stage on outcome after corneal crosslinking | BMC Ophthalmology | Full Texthttps://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-022-02425-8
This study aimed to analyze if the outcome after corneal crosslinking (CXL) in progressive keratoconus patients depends on the stage at which the procedure is performed. This knowledge would help to improve success of CXL and to define surgery indications in those patients. […] BCVA showed a significantly higher improvement after CXL in the early stage of keratoconus compared to a higher stage. However, the postinterventional tomographic values did not differ significantly between the different modified Krumeich stages. The significantly higher improvement in BCVA after CXL in the early stage might indicate that earlier intervention provides a higher subjective benefit to the individual. […] Our data suggest that patients benefit from corneal CXL regardless of modified Krumeich stages. However, we observed trends towards a comparatively higher improvement in visual acuity in the group with the early keratoconus stage. Larger controlled studies over longer observation periods should be conducted to verify these observations. These findings may optimize the management and indication of corneal CXL in keratoconus patients.
- #1https://journals.lww.com/ijo/fulltext/2024/72040/current_concepts_in_the_management_of_cataract.11.aspx
Keratoconus (KCN) is a non-inflammatory corneal condition with onset commonly in early adulthood, which gradually progresses and often stabilizes later in life. […] People with KCN are known to develop a cataract earlier than people without. […] A visually significant cataract in a KCN patient can pose a challenge. […] Choosing an appropriate IOL and precise calculation of the IOL power in eyes with variable and inconsistent keratometry (K) and axial length (AL) readings are the main challenges. […] Therefore, a tailored rather than a one-size-fits-all approach might be more suited in these cases. […] Late-onset progression of KCN is an important entity that must be kept in mind while planning cataract surgery in these people, despite the traditional teaching that regardless of treatment, its progression is limited or does not progress after the age of 30 years due to naturally occurring cross-links in the cornea.
- #1 Predictability of Intraocular Lens Power Calculation for Cataract with Keratoconus: A Multicenter Study | Scientific Reportshttps://www.nature.com/articles/s41598-018-20040-w
This study was aimed to assess the predictability of intraocular lens (IOL) power calculation after cataract surgery for keratoconus. […] The achieved refraction was significantly more hyperopic than the targeted refraction, when keratometric readings were used (p=0.001). […] We found a significant correlation between the prediction error and the mean keratometry (Pearson correlation coefficient r=0.545, p0.001). […] Phacoemulsification with IOL implantation appeared to be safe and effective, and the accuracy was also good in mild keratoconus, but not in severe keratoconus. […] It should be noted that that a large amount of hyperopic shift occurred especially in advanced keratoconic patients, when keratometric readings were used for IOL power calculation, and that a slight, but significant, myopic shift occurred, when total corneal refractive power was used.
- #1 Predictability of Intraocular Lens Power Calculation for Cataract with Keratoconus: A Multicenter Study | Scientific Reportshttps://www.nature.com/articles/s41598-018-20040-w
Our multicenter study showed that phacoemulsification with IOL implantation was good in measures of safety and efficacy in cataractous patients with keratoconus, and that the predictability was also good in mild keratoconus, but not in moderate to severe keratoconus. […] We should be aware that a large amount of hyperopic shift occurred in advanced keratoconus patients, when the keratometric readings were used for the IOL power calculation, and that a slight, but significant, myopic shift occurred, when total corneal refractive power was used. […] We believe that this information is helpful for determining the accurate IOL power in keratoconus in daily practice.
- #1 IOL Power Calculation in Keratoconus | SpringerLinkhttps://link.springer.com/chapter/10.1007/978-3-031-50666-6_66
Keratoconus is a progressive disorder characterised by central or paracentral corneal thinning and ectasia. The changes in the keratoconic cornea affect multiple aspects of IOL power calculation and keratoconus remains one of the last major challenges existing in IOL power calculation. […] The significant barriers to accuracy in keratoconus patients, poor understanding on how to conduct IOL power studies, and small patient sample sizes have limited the refractive outcomes in keratoconus patients. […] Keratoconus leads to a hyperopic prediction error which has been well established in studies by Watson et al. […] The first paper in keratoconus patients to follow the correct guidelines on IOL power calculation studies was done by Savini et al. in JCRS. […] The study demonstrated that the amount of hyperopic error worsened with the stage of keratoconus (+0.44 D in stage 1 up to +3.01 D in stage 3 for the SRK/T formula) and that the accuracy of IOL power calculation worsened with an increasing stage of keratoconus.
- #1 IOL Power Calculation in Keratoconus | SpringerLinkhttps://link.springer.com/chapter/10.1007/978-3-031-50666-6_66
The Kane keratoconus formula should be used in keratoconus patients with either the Barrett or SRK/T formulas being the next most accurate. There is currently not enough available evidence to recommend the Barrett True-K formula for keratoconus. The management of patient expectation should be central to the informed consent of these patients and reasonable figures to discuss with patients (when using the Kane keratoconus formula) are: 60% within 0.50 D if the average keratometry is 48 dioptres; 40% if the average keratometry is 48-53; and 25% if the average keratometry is 53 D.
- #1 Keratoconus: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/1194693-overview
Most patients with keratoconus do well with rigid contact and scleral lens care. […] About 10%-20% of patients with keratoconus eventually require corneal transplantation, but this number is believed to increase if good contact lens care is unavailable and decrease with early CXL treatment. […] Data suggest that this disease, although progressive, stabilizes after some time in most patients.
- #1 Prognostic factors for the progression of keratoconus – PubMedhttps://pubmed.ncbi.nlm.nih.gov/8127564/
Purpose: The progression of keratoconus to a stage where penetrating keratoplasty (PK) is required for visual rehabilitation has considerable implications for affected patients. To assist with counselling, the authors have attempted to identify which factors measurable early in the course of the disease may indicate the likelihood of subsequent surgery. […] Several clinical variables can be measured in patients at the presentation of keratoconus that influence the probability of a subsequent PK.
- #1https://link.springer.com/article/10.1007/s10462-024-11016-6
The proposed system is not only designed for accuracy but also for clinical efficiency. […] The proposed multi-source detection system based on transformers represents a significant advancement in the field of keratoconus management and addresses the limitations of existing diagnostic techniques, which often rely on single-source data and subjective assessments, by offering a comprehensive and objective framework for early detection and management of keratoconus. […] The transformer-based model outperforms traditional machine learning methods, such as SVM, Random Forests, and CNNs, in terms of accuracy, precision, recall, and F-score, while maintaining lower execution times, making it a highly efficient and effective tool for clinical settings.
- #2https://link.springer.com/article/10.1007/s10462-024-11016-6
Keratoconus is a progressive eye disease characterized by the thinning and conical distortion of the cornea, leading to visual impairment. Early and accurate detection is essential for effective management and treatment. […] The early and accurate detection of keratoconus progression is critical to preventing vision loss and treating the disease effectively. […] Given the limitations of these existing methods in handling diverse data sources, and detecting and monitoring early-stage keratoconus, there is a pressing need for a more comprehensive and objective approach. […] This innovative methodology holds the potential to revolutionize keratoconus management by enabling earlier and more precise interventions, ultimately enhancing patient outcomes. […] Our work leverages the high sensitivity of transformers to model complex dependencies across multimodal datasets, allowing for more accurate early detection and differentiation between normal, suspected, and definite keratoconus cases.
- #2 Keratoconus: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/1194693-overview
Most patients with keratoconus do well with rigid contact and scleral lens care. […] About 10%-20% of patients with keratoconus eventually require corneal transplantation, but this number is believed to increase if good contact lens care is unavailable and decrease with early CXL treatment. […] Data suggest that this disease, although progressive, stabilizes after some time in most patients.
- #2 Natural history and predictors for progression in pediatric keratoconus | Scientific Reportshttps://www.nature.com/articles/s41598-023-32176-5
We studied the demographic and clinical predictors associated with keratoconus progression in a pediatric population. […] The general Kaplan-Meyer curves showed no differences between RE/LE or BE/WE. […] Steepest corneas are predictors of faster progression. Allergy is also a predictor of keratoconus progression in RE. […] The present work reveals that the major factors associated with progression were: Kmax55 D (for LE, BE, and WE), and presence of allergy (for RE). […] Our data reinforce that the steepest corneas are associated with faster progression and therefore need close follow-up. The presence of allergy is also a predictor of keratoconus progression.
- #2https://journals.lww.com/ijo/fulltext/2024/72040/current_concepts_in_the_management_of_cataract.11.aspx
However, certain eyes with KCN do progress, the natural mechanism of which is not yet determined but could be linked to the pursued eye rubbing. […] Successful cataract surgery depends on the careful management of inflammation and modifiable risk factors such as eye rubbing, which can impact prognosis and outcomes. […] The management of cataracts in patients with KCN requires extensive preoperative intraoperative and postoperative planning to achieve optimal visual outcomes.
- #2 Predicting Keratoconus Progression and Need for Corneal Crosslinking Using Deep Learninghttps://www.mdpi.com/2077-0383/10/4/844
We aimed to predict keratoconus progression and the need for corneal crosslinking (CXL) using deep learning (DL). […] The primary purpose of CXL is to halt the progression of keratoconus. […] However, there are no definitive criteria for predicting keratoconus progression at present. […] Therefore, a method for predicting the progression and the need for CXL in keratoconus cases at the first examination is required. […] In the present work, we aimed to determine the need for CXL to halt keratoconus progression using DL. […] The predictive performance of keratoconus progression is shown in Table 2 and Figure 4. […] When the possibility for keratoconus progression was combined with patientsâ age, the AUC values were 0.783 (0.721â0.845) with the axial map, 0.784 (0.722â0.846) with the corneal pachymetry map, and 0.814 (0.755â0.872) using both maps. […] We attempted to predict the exacerbation of keratoconus that required CXL aftertime using DL and showed that the axial map or the pachymetry map combined with the patientsâ age were useful indicators of the need for CXL, with about 80% probability.
- #2 Predicting factors for the efficacy of cross-linking for keratoconus | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263528
To evaluate predictors for success in corneal crosslinking (CXL) for keratoconus in a large cohort and extended follow-up. […] CXL for keratoconus is a highly effective treatment, as evident by its effects on the outcome measures: Delta Kmax and Delta LogMAR. […] CXL was more successful in eyes with high Kmaxpre, high SEpre, and high LogMARpre, which express disease severity. […] The non-accelerated epithelium-off protocol was associated with greater flattening of corneal curvature but did not show a better effect on visual acuity as compared to the other CXL protocols. […] Knowledge of pre-operative predictors for a successful outcome in CXL may have clinical implications for ophthalmologists when considering the indications for managing KC patients. […] In our multivariate analysis, corneal flattening effect post-CXL, was significantly affected by higher Kmaxpre, higher SEpre, higher MeanKpre, and non-accelerated CXL procedure.
- #2 Predicting factors for the efficacy of cross-linking for keratoconus | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263528
We also demonstrated that an improvement of visual function post-CXL was significantly affected by a higher LogMARpre, a higher SEpre, and a lower MeanKpre. […] Overall, these results show that in patients with more advanced disease, CXL might have a more potent effect. […] In univariate and multivariate analysis, non-accelerated CXL was correlated with significantly more negative Delta Kmax compared to accelerated CXL. […] In univariate and multivariate analysis, higher Kmaxpre was correlated with significantly more negative Delta Kmax. […] Higher baseline spherical equivalent (SE) correlated with greater improvement of Kmax in univariate analysis and visual acuity in multivariate analysis.
- #2 Predictability of Intraocular Lens Power Calculation for Cataract with Keratoconus: A Multicenter Study | Scientific Reportshttps://www.nature.com/articles/s41598-018-20040-w
This study was aimed to assess the predictability of intraocular lens (IOL) power calculation after cataract surgery for keratoconus. […] The achieved refraction was significantly more hyperopic than the targeted refraction, when keratometric readings were used (p=0.001). […] We found a significant correlation between the prediction error and the mean keratometry (Pearson correlation coefficient r=0.545, p0.001). […] Phacoemulsification with IOL implantation appeared to be safe and effective, and the accuracy was also good in mild keratoconus, but not in severe keratoconus. […] It should be noted that that a large amount of hyperopic shift occurred especially in advanced keratoconic patients, when keratometric readings were used for IOL power calculation, and that a slight, but significant, myopic shift occurred, when total corneal refractive power was used.
- #2 Predictability of Intraocular Lens Power Calculation for Cataract with Keratoconus: A Multicenter Study | Scientific Reportshttps://www.nature.com/articles/s41598-018-20040-w
Our multicenter study showed that phacoemulsification with IOL implantation was good in measures of safety and efficacy in cataractous patients with keratoconus, and that the predictability was also good in mild keratoconus, but not in moderate to severe keratoconus. […] We should be aware that a large amount of hyperopic shift occurred in advanced keratoconus patients, when the keratometric readings were used for the IOL power calculation, and that a slight, but significant, myopic shift occurred, when total corneal refractive power was used. […] We believe that this information is helpful for determining the accurate IOL power in keratoconus in daily practice.
- #2 IOL Power Calculation in Keratoconus | SpringerLinkhttps://link.springer.com/chapter/10.1007/978-3-031-50666-6_66
Keratoconus is a progressive disorder characterised by central or paracentral corneal thinning and ectasia. The changes in the keratoconic cornea affect multiple aspects of IOL power calculation and keratoconus remains one of the last major challenges existing in IOL power calculation. […] The significant barriers to accuracy in keratoconus patients, poor understanding on how to conduct IOL power studies, and small patient sample sizes have limited the refractive outcomes in keratoconus patients. […] Keratoconus leads to a hyperopic prediction error which has been well established in studies by Watson et al. […] The first paper in keratoconus patients to follow the correct guidelines on IOL power calculation studies was done by Savini et al. in JCRS. […] The study demonstrated that the amount of hyperopic error worsened with the stage of keratoconus (+0.44 D in stage 1 up to +3.01 D in stage 3 for the SRK/T formula) and that the accuracy of IOL power calculation worsened with an increasing stage of keratoconus.
- #2 Keratoconus – Wikipediahttps://en.wikipedia.org/wiki/Keratoconus
Patients with keratoconus typically present initially with mild astigmatism and myopia, commonly at the onset of puberty, and are diagnosed by the late teenage years or early 20s. […] A diagnosis of the disease at an early age may indicate a greater risk of severity in later life. […] The course of the disorder can be quite variable, with some patients remaining stable for years or indefinitely, while others progress rapidly or experience occasional exacerbations over a long and otherwise steady course. Most commonly, keratoconus progresses for a period of 10 to 20 years before the course of the disease generally ceases in the third and fourth decades of life. […] In advanced cases, bulging of the cornea can result in a localized rupture of Descemet’s membrane, an inner layer of the cornea. […] Although disconcerting to the patient, the effect is normally temporary and after a period of six to eight weeks, the cornea usually returns to its former transparency. […] The recovery can be aided nonsurgically by bandaging with an osmotic saline solution.
- #2 Keratoconus – Sjónlaghttps://en.sjonlag.is/EyeCare/Keratoconus/
Although it is difficult to predict how fast or how much the disease will develop per individual, the disease does not lead to total blindness. […] In the worst cases, the sight may be very bad. With today’s therapies, most people to maintain a normal life. […] Most of the time, vision and daily life is only disrupted while people are changing or getting used to lenses, or waiting for the vision to stabilize after corneal transplantation.
- #2 Keratoconus: Symptoms, Causes & Treatmenthttps://my.clevelandclinic.org/health/diseases/14415-keratoconus
With treatment, the outlook for someone with keratoconus is good. […] Every person is different. Some people have mild cases of keratoconus that dont progress. Other people have cases that do progress. No one can predict what will happen in every case. […] Untreated keratoconus can lead to permanent vision loss. The changes to the cornea make it difficult for your eye to focus with or without eyeglasses or standard soft contact lenses.
- #3https://journals.lww.com/ijo/fulltext/2024/72040/current_concepts_in_the_management_of_cataract.11.aspx
Keratoconus (KCN) is a non-inflammatory corneal condition with onset commonly in early adulthood, which gradually progresses and often stabilizes later in life. […] People with KCN are known to develop a cataract earlier than people without. […] A visually significant cataract in a KCN patient can pose a challenge. […] Choosing an appropriate IOL and precise calculation of the IOL power in eyes with variable and inconsistent keratometry (K) and axial length (AL) readings are the main challenges. […] Therefore, a tailored rather than a one-size-fits-all approach might be more suited in these cases. […] Late-onset progression of KCN is an important entity that must be kept in mind while planning cataract surgery in these people, despite the traditional teaching that regardless of treatment, its progression is limited or does not progress after the age of 30 years due to naturally occurring cross-links in the cornea.
- #3https://link.springer.com/article/10.1007/s10462-024-11016-6
Keratoconus is a progressive eye disease characterized by the thinning and conical distortion of the cornea, leading to visual impairment. Early and accurate detection is essential for effective management and treatment. […] The early and accurate detection of keratoconus progression is critical to preventing vision loss and treating the disease effectively. […] Given the limitations of these existing methods in handling diverse data sources, and detecting and monitoring early-stage keratoconus, there is a pressing need for a more comprehensive and objective approach. […] This innovative methodology holds the potential to revolutionize keratoconus management by enabling earlier and more precise interventions, ultimately enhancing patient outcomes. […] Our work leverages the high sensitivity of transformers to model complex dependencies across multimodal datasets, allowing for more accurate early detection and differentiation between normal, suspected, and definite keratoconus cases.
- #3 Predicting Keratoconus Progression and Need for Corneal Crosslinking Using Deep Learninghttps://www.mdpi.com/2077-0383/10/4/844
We aimed to predict keratoconus progression and the need for corneal crosslinking (CXL) using deep learning (DL). […] The primary purpose of CXL is to halt the progression of keratoconus. […] However, there are no definitive criteria for predicting keratoconus progression at present. […] Therefore, a method for predicting the progression and the need for CXL in keratoconus cases at the first examination is required. […] In the present work, we aimed to determine the need for CXL to halt keratoconus progression using DL. […] The predictive performance of keratoconus progression is shown in Table 2 and Figure 4. […] When the possibility for keratoconus progression was combined with patientsâ age, the AUC values were 0.783 (0.721â0.845) with the axial map, 0.784 (0.722â0.846) with the corneal pachymetry map, and 0.814 (0.755â0.872) using both maps. […] We attempted to predict the exacerbation of keratoconus that required CXL aftertime using DL and showed that the axial map or the pachymetry map combined with the patientsâ age were useful indicators of the need for CXL, with about 80% probability.
- #3 Predicting factors for the efficacy of cross-linking for keratoconus | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263528
To evaluate predictors for success in corneal crosslinking (CXL) for keratoconus in a large cohort and extended follow-up. […] CXL for keratoconus is a highly effective treatment, as evident by its effects on the outcome measures: Delta Kmax and Delta LogMAR. […] CXL was more successful in eyes with high Kmaxpre, high SEpre, and high LogMARpre, which express disease severity. […] The non-accelerated epithelium-off protocol was associated with greater flattening of corneal curvature but did not show a better effect on visual acuity as compared to the other CXL protocols. […] Knowledge of pre-operative predictors for a successful outcome in CXL may have clinical implications for ophthalmologists when considering the indications for managing KC patients. […] In our multivariate analysis, corneal flattening effect post-CXL, was significantly affected by higher Kmaxpre, higher SEpre, higher MeanKpre, and non-accelerated CXL procedure.
- #4 Predicting factors for the efficacy of cross-linking for keratoconus | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263528
To evaluate predictors for success in corneal crosslinking (CXL) for keratoconus in a large cohort and extended follow-up. […] CXL for keratoconus is a highly effective treatment, as evident by its effects on the outcome measures: Delta Kmax and Delta LogMAR. […] CXL was more successful in eyes with high Kmaxpre, high SEpre, and high LogMARpre, which express disease severity. […] The non-accelerated epithelium-off protocol was associated with greater flattening of corneal curvature but did not show a better effect on visual acuity as compared to the other CXL protocols. […] Knowledge of pre-operative predictors for a successful outcome in CXL may have clinical implications for ophthalmologists when considering the indications for managing KC patients. […] In our multivariate analysis, corneal flattening effect post-CXL, was significantly affected by higher Kmaxpre, higher SEpre, higher MeanKpre, and non-accelerated CXL procedure.
- #4https://link.springer.com/article/10.1007/s10462-024-11016-6
Keratoconus is a progressive eye disease characterized by the thinning and conical distortion of the cornea, leading to visual impairment. Early and accurate detection is essential for effective management and treatment. […] The early and accurate detection of keratoconus progression is critical to preventing vision loss and treating the disease effectively. […] Given the limitations of these existing methods in handling diverse data sources, and detecting and monitoring early-stage keratoconus, there is a pressing need for a more comprehensive and objective approach. […] This innovative methodology holds the potential to revolutionize keratoconus management by enabling earlier and more precise interventions, ultimately enhancing patient outcomes. […] Our work leverages the high sensitivity of transformers to model complex dependencies across multimodal datasets, allowing for more accurate early detection and differentiation between normal, suspected, and definite keratoconus cases.